COPD Clinical Trials

Showing 781-800 of 1,501 trials

An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)

NCT04041193

The SIDERA\^B telerehabilitation system is enabled by a multi-domain, multi-device platform providing at home multi-component rehabilitation, targeting cardiovascular (Chronic Heart Failure, CHF), pulmonary (Chronic Obstructive Pulmonary Disease, COPD) and neurodegenerative (Parkinson Disease, PD) chronic diseases. The rehabilitation program embeds engagement activities for patient and caregiver, to empower appropriation of the SIDERA\^B care routines and fuel their well-being resources. The multidisciplinary layering of SIDERA\^B is reflected in the validation protocol including a) clinical and well-being evaluation through a cross-over study confronting usual care with the SIDERA\^B activities; b) technological evaluation: Health Technology Assessment for organizational, legal and equity impacts; c) economic evaluation: process mapping and budget impact analysis to define a sustainable reimbursement process for the innovative telerehabilitation pathway.

Parkinson Disease (PD)Chronic Heart Failure (CHF)Chronic Obstructive Pulmonary Disease (COPD)

Fondazione Don Carlo Gnocchi Onlus150 participantsStarted Jul 2019

Milan, Italy

COMPLETEDPhase 1/2

Imaging Regional Lung Defect Severity

NCT01640288

The purpose of this study is to develop and evaluate the usefulness of magnetic resonance imaging (MRI) using inert perfluorinated gases mixed with oxygen for regional assessment of pulmonary function. The proposed study seeks to determine regional qualitative and quantitative lung function information in the context of the clinical trajectory of chronic obstructive pulmonary disease (COPD) defined by the cross sectional cohort component. In the case of these perfluorinated (PFx)/oxygen mixtures, the availability of multi-liter quantities allows for wash-in/wash-out image acquisition and analysis allowing direct measures of gas trapping in a manner not easily achieved with any existing modality.

COPD

Hal C Charles171 participantsStarted Jan 2013

Durham, North Carolina, United States

An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)

Imaging Regional Lung Defect Severity

Related Searches

Difference in the Metabolic Characteristics of COPD Patients and Healthy Adults

Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment

Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD

The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases

Anxiety and Depression in COPD; Prevalence, Detection and Prognosis

The Effect of Beclomethasone/Formoterol in Extra-fine Formulation on Quality of Life and SAD in COPD Patients.

A Sedentary Behaviour Reduction Intervention for People With COPD

Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®

Study on the Prevention and Control System of Chronic Airway Diseases

High Flow Nasal Therapy Versus Noninvasive Ventilation in COPD Exacerbation

Qui Gong Programme vs Short Form Sun Style Tai Chi in COPD Patients

Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.

Assessing Exercise Capacity After PulseHaler™ Treatment in GOLD II-IV COPD Patients

Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome

Comprehensive Care Program SBRT

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases

BACE Trial Substudy 2 - FarmEc Substudy

Isolation of Circulating Pulmonary Cells in COPD and Its Relationship With Clinical Relevant Outcomes (IbICEnCa)